CORPORATE KEY INDIVIDUALS
Edward Hlozek, CEO and Chairman
Most recently CEO of Mind & Associates, Inc., Edward has been a senior level business executive, founder and Director of interventional and surgical/medical minimally invasive companies in cardiac, neurologic, orthopedic, urologic,
gynecologic and ENT companies. He has been responsible
for financial and clinical introductory oversight for Class I, II &
III Devices for minimally invasive techniques in all surgical
specialties, including RF therapy devices. Designer and
patent holder for the current transcatheter platform
technologies of ValveCure.
Richard Heuser, MD, FACC, FACP,
Internationally-recognized cardiologist, inventor, educator, author and one of the early pioneers of the angioplasty procedure. Author of over 180 research studies, clinical textbooks, and holder of over 50 patents. Scientific Advisory Board Chair for ValveCure, and Chief of Cardiology at St.
Tom Witzel, VP Operations
Tom has extensive experience managing and participating in pre-clinical procedures and studies. Working with leading
cardiovascular technologies, including heart valves and other surgical and endovascular devices, Tom has collaborated
with prominent cardiovascular physicians in the U.S., Europe,
and China. As an employee and consultant, Tom has
completed pre-clinical projects for Edwards Lifesciences,
Ventrica, HeartPort, MiCardia, and 3F Therapeutics.
John Osth, CFO
CEO of NanoSomix, previously CEO Celula, Inc., Chairman & CEO of QuantumCor Inc., of which he has been a founder. John has also held senior level positions at Baxter Healthcare including President of the Immunotherapy Division and head of European R&D.
Board of Directors
- Edward Hlozek, Chairman
- Richard Heuser, MD, SAB Chairman
- John Osth
- Thomas Witzel
Scientific Advisory Board
- Richard Heuser, MD
- David Adams, MD
- Peter Block, MD
- Randy Chitwood, MD
- Saibal Kar, MD
- Jeffrey Milliken, MD